Aims and Scope

Molecular Biology & Nanomedicine (MBN) will publish all areas of molecular biology and nano-medicine, including basic research in nanobiology, technology transformation, industrialization demonstration, etc. This journal is aimed to provide a platform for communication, sharing, and discussion in the fields of biology and nanoscience for scientists, scholars, and researchers.

The areas covered include (but are not restricted to):

biomolecules/surfaces interactions studies
self-assembly of biological molecules
artificial cells
regenerative medicine
gene therapy/diagnostics
infectious disease
new drug R&D
molecular probes
targeted drugs
nanotechnology
nanobiotechnology
nanomedicine
stem cell and tissue engineering
nanomedical devices
biomimetics, and bioinformatics
interactions of nanomaterials with cells, tissues

Open Access

All articles published by Molecular Biology & Nanomedicine will be Open-Access articles, are made freely and permanently accessible online immediately from the date of publication. Articles are published under a Creative Commons Attribution 4.0 International License. Authors retain the copyright of their works.

Articles published in MBN will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). Techland publishing will insert the following note at the published text:

© 2020 the authors. This article is an open access article licensed under the terms and conditions of the CREATIVE COMMONS ATTRIBUTION (CC BY) LICENSE (http://creativecommons.org/licenses/by/4.0/).

Peer Review and Acceptance

The acceptance criteria for this Journal are based on the quality, originality and novelty of the researches, as well as the significance to readership. Except where otherwise stated, the Journal adheres to rigorous peer review process and undergoes single-blind peer review for all the manuscripts. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the quality and relevance requirements.